Osaic Holdings’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,708
| Closed | -$31.1K | – | 7760 |
|
|
2025
Q1 | $31.1K | Sell |
7,708
-20,443
| -73% | -$68.1K | ﹤0.01% | 5053 |
|
|
2024
Q4 | $90.1K | Buy |
28,151
+22,434
| +392% | +$76.1K | ﹤0.01% | 4261 |
|
|
2024
Q3 | $12.8K | Buy |
5,717
+5,167
| +939% | +$11.9K | ﹤0.01% | 5659 |
|
|
2024
Q2 | $1.18K | Sell |
550
-134,627
| -100% | -$240K | ﹤0.01% | 6764 |
|
|
2024
Q1 | $277K | Sell |
135,177
-28,106
| -17% | -$56.1K | ﹤0.01% | 3400 |
|
|
2023
Q4 | $374K | Buy |
163,283
+56,195
| +52% | +$122K | ﹤0.01% | 3401 |
|
|
2023
Q3 | $182K | Buy |
107,088
+39,083
| +57% | +$88.8K | ﹤0.01% | 4064 |
|
|
2023
Q2 | $168K | Buy |
68,005
+26,597
| +64% | +$72.7K | ﹤0.01% | 4035 |
|
|
2023
Q1 | $93.2K | Buy |
41,408
+7,255
| +21% | +$36.4K | ﹤0.01% | 4510 |
|
|
2022
Q4 | $175K | Buy |
34,153
+9,959
| +41% | +$71.7K | ﹤0.01% | 3973 |
|
|
2022
Q3 | $252K | Buy |
24,194
+4,892
| +25% | +$58.3K | ﹤0.01% | 3531 |
|
|
2022
Q2 | $199K | Buy |
19,302
+1,944
| +11% | +$25.5K | ﹤0.01% | 3805 |
|
|
2022
Q1 | $307K | Buy |
17,358
+7,508
| +76% | +$161K | ﹤0.01% | 3664 |
|
|
2021
Q4 | $306K | Buy |
9,850
+3,344
| +51% | +$111K | ﹤0.01% | 3544 |
|
|
2021
Q3 | $215K | Buy |
6,506
+5,374
| +475% | +$159K | ﹤0.01% | 3832 |
|
|
2021
Q2 | $33K | Sell |
1,132
-113
| -9% | -$3.13K | ﹤0.01% | 5340 |
|
|
2021
Q1 | $39K | Buy |
1,245
+282
| +29% | +$9.45K | ﹤0.01% | 5043 |
|
|
2020
Q4 | $25K | Buy |
963
+55
| +6% | +$1.39K | ﹤0.01% | 5011 |
|
|
2020
Q3 | $24K | Buy |
908
+148
| +19% | +$3.55K | ﹤0.01% | 4810 |
|
|
2020
Q2 | $15K | Hold |
760
| – | – | ﹤0.01% | 4954 |
|
|
2020
Q1 | $11K | Buy |
+760
| New | +$13.5K | ﹤0.01% | 4940 |
|
Osaic Holdings's CKPT Position: Q2 2025 in Review
Osaic Holdings sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 7,708 shares — an estimated $31.1K sold.
Osaic Holdings first reported a position in CKPT in Q1 2020 and held it in 21 quarters. The position peaked at $374K in Q4 2023. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.
- Osaic Holdings reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
- Osaic Holdings sold 7,708 Checkpoint Therapeutics shares in Q2 2025, an estimated $31.1K.
- Osaic Holdings first reported a position in Checkpoint Therapeutics in Q1 2020 and held it in 21 quarters.
- Osaic Holdings's Checkpoint Therapeutics position peaked at $374K in Q4 2023.
- 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.
Based on Osaic Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.